Efficacy and safety of intranasal xylometazoline and ipratropium in patients with common cold

Bibliography

• TyrrZell DA, Cohen S, Schlarb JE. Signs and symptoms in common colds. Epidemiol Infect 1993;111:143-56
   PubMedGoogle Scholar
• Eccles R, Loose I, Jawad M, Nyman L. Effects of acetylsalicylic acid on sore throat pain and other pain symptoms associated with acute upper respiratory tract infection. Pain Med 2003;4(2):118-24
   PubMed Web of Science ®Google Scholar
• Arruda E, Pitkäranta A, Witek TJ Jr, et al. Frequency and natural history of rhinovirus infections in adults during autumn. J Clin Microbiol 1997;35:2864-68
   PubMed Web of Science ®Google Scholar
• Scarupa MD, Sveum RJ, Schoenwetter WF, Kaliner MA. Anticholinergic agents, guaifenesin and decongestants in the treatment of rhinitis. Second edition. In: Kaliner MA, editor, Current reviews of rhinitis. Philadelphia, Pa: Current Medicine, Inc; 2002
   Google Scholar
• Gentile DA, Friday G, Skoner DP. Management of rhinitis: antihistamines and decongestants. Immunol Allergy Clin North Am 2002;20:355-68
   Web of Science ®Google Scholar
• Clarke RW, Cook JA, Jones AS. The effect of nasal mucosal vasoconstriction on nasal air-flow sensation. Clin Otolaryngol 1995;20:72-3
   PubMed Web of Science ®Google Scholar
• Simasek M, Blandino DA. Treatment of the common cold. Am Fam Physician 2007;75:515-20
   PubMed Web of Science ®Google Scholar
• Borum P, Gronborg H, Brofeldt S, Mygind N. Nasal reactivity in rhinitis. Eur J Respir Dis 1983;64:65-71
   Google Scholar
• Worrall G. Common cold. Can Fam Phys 2007;53:1735-6
   PubMed Web of Science ®Google Scholar
• Heikkinen T, Jarvinen A. The common cold. Lancet 2003;361:51-9
   PubMed Web of Science ®Google Scholar
• Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis 2001;33:757-62
   PubMed Web of Science ®Google Scholar
• Rowlands DJ. Rhinoviruses and cells: molecular aspects. Am J Respir Crit Care Med 1995;152:S31-5
   Google Scholar
• Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect Dis 2005;5:718-25
   PubMed Web of Science ®Google Scholar
• Kirkpatrick GL. The common cold. Primary Care 1996;23:657-75
   PubMed Web of Science ®Google Scholar
• Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med 2003;163:487-94
   PubMed Web of Science ®Google Scholar
• Johnston S, Holgate S. Epidemiology of viral respiratory infections. In: Myint S, Taylor-Robinson D, editors, Viral and other infections of the human respiratory tract. London: Chapman & Hall, 1996. p. 1-38
   Google Scholar
• Hayden FG, Diamond L, Wood PB, et al. Effectiveness and safety of intranasal ipratropium bromide in common colds. A randomised, double-blind, placebo-controlled trial. Ann Intern Med 1996;125:89-97
   PubMed Web of Science ®Google Scholar
• Eccles R. Mechanisms of symptoms of the common cold and influenza. Br J Hosp Med 2007;68:71-5
   PubMed Web of Science ®Google Scholar
• Van Cauwenberge PB, van Kempen MJP, Bachert C. The common cold. Acta oto-rhino-laryngologica belg 2000;54:397-401
   PubMedGoogle Scholar
• Diamond L, Dockhorn RJ, Kisicki JC, et al. A dose-response study of the safety and efficacy of ipratropium bromide nasal spray in the treatment of the common cold. J Allergy Clin Immunol 1995;95:1139-46
   PubMedGoogle Scholar
• Spector SL. The common cold: current therapy and natural history. J Allergy Clin Immunol 1995;95:1133-8
   PubMed Web of Science ®Google Scholar
• Kaliner MA, Lieberman P. Examination of the nasal cavity. In: Kaliner MA, editor, Current reviews of rhinitis. Philadelphia: Current Medicine, Inc., 2002
   Google Scholar
• Widdicombe J. Microvascular anatomy of the nose. Allergy 1997;52:7-11
   PubMed Web of Science ®Google Scholar
• Eccles R. Anatomy and physiology of the nose and control of nasal airflow. Sixth edition. In: Adkinson NO, Bochner B, Yunginger J, et al, editors, Middleton's allergy, principles and practice. Philadelphia: Mosby, 2003. p. 775-87
   Google Scholar
• Eccles R. Nasal airflow in health and disease. Acta Otolaryngol 2000;120:580-95
   PubMed Web of Science ®Google Scholar
• Naclerio RM, Baroody FM. In vivo human models for the study of anticholinergic drugs. J Allergy Clin Immunol 1995;95:1069-79
   PubMedGoogle Scholar
• Wynne JW. Obstruction of the nose and breathing during sleep. Chest 1982;82:657-8
   PubMedGoogle Scholar
• Turner RB. Epidemiology, pathogenesis and treatment of the common cold. Ann Allergy Asthma Immunol 1997;78:531-9
   PubMed Web of Science ®Google Scholar
• Gwaltney J Jr, Hendley JO. Transmission of experimental rhinovirus infection by contaminated surfaces. Am J Epidemiol 1982;116:828-33
   PubMed Web of Science ®Google Scholar
• Hendley JO, Gwaltney J Jr. Mechanisms of transmission of rhinovirus infections. Epidemiol Rev 1988;10:243-58
   PubMedGoogle Scholar
• Gwaltney J Jr, Druce HM. Efficacy of brompheniramine maleate for the treatment of rhinovirus colds. Clin Infect Dis 1997;25:1188-94
   PubMedGoogle Scholar
• Woodwell DA, Cherry DK. National ambulatory medical care survey: 2002 summary. Adv Data 2004;346:1-44
   PubMedGoogle Scholar
• Kaufman DW, Kelly JP, Rosenberg L, et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002;287:337-44
   PubMed Web of Science ®Google Scholar
• Kogan MD, Pappas G, Yu SM, Kotelchuck M. Over-the-counter medication use among US preschool-age children. JAMA 1994;272:1025-30
   PubMed Web of Science ®Google Scholar
• De Sutter AI, Lemiengre M, Campbell H, Mackinnon HF. Antihistamines for the common cold. Cochrane Database Syst Rev 2003, Issue 3.Art.No.:CD001267
   Google Scholar
• Gustafson LM, Proud D, Hendley JO, et al. Oral prednisolone therapy in experimental rhinovirus infections. J Allergy Clin Immunol 1996;97:1009-14
   PubMed Web of Science ®Google Scholar
• Puhakka T, Mäkelä MJ, Malström K, et al. The common cold: effects of intranasal fluticasone propionate treatment. J Allergy Clin Immunol 1998;101:726-31
   PubMed Web of Science ®Google Scholar
• Farr BM, Gwaltney J Jr, Hendley JO, et al. A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection. J Infect Dis 1990;162:1173-7
   PubMed Web of Science ®Google Scholar
• Winther B, Mygind N. The therapeutic effectiveness of ibuprofen on the symptoms of naturally acquired common colds. Am J Rhinol 2001;15:239-42
   PubMedGoogle Scholar
• Eccles R, Eriksson M, Garreffa S, Chen S. The nasal decongestant effect of xylometazoline in the common cold. Am J Rhinol 2008;22:1-22
   PubMedGoogle Scholar
• Maranta CA, Simmen D. Decongestant nasal spray. Results of a rhinomanometric double-blind study. Schweiz Med Wochenschr 1996;126:1875-80
   PubMedGoogle Scholar
• Williams RG, Eccles R. Nasal airflow asymmetry and the effects of a topical nasal decongestant. Rhinology 1992;30:277-82
   PubMedGoogle Scholar
• Hamilton LH. Effects of xylometazoline nasal spray on nasal conductance in subjects with coryza. J Otolaryngol 1981;10:109-16
   PubMedGoogle Scholar
• Kim KT, Kerwin E, Landwehr L, et al. Use of 0.06% ipratropium bromide nasal spray in children aged 2 to 5 years with rhinorrhea due to a common cold or allergies. Ann Allergy Asthma Immunol 2005;94:73-9
   PubMedGoogle Scholar
• Østberg B, Winther B, Borum P, Mygind N. Common cold and high-dose ipratropium bromide: use of anticholinergic medication as an indicator of reflex-mediated hypersecretion. Rhinology 1997;35:58-62
   PubMedGoogle Scholar
• Dockhorn RJ, Grossman J, Posner M, et al. A double-blind, placebo-controlled study of the safety and efficacy of ipratropium bromide nasal spray versus placebo in patients with the common cold. J Allergy Clin Immunol 1992;90:1076-82
   PubMedGoogle Scholar
• Gaffey MJ, Hayden FB, Boyd JC, Gwaltney J Jr. Ipratropium bromide treatment of experimental rhinovirus infection. Antimicrob Agents Chemother 1988;32:1644-7
   PubMedGoogle Scholar
• Borum P, Olsen L, Winther B, Mygind N. Ipratropium nasal spray: a new treatment for rhinorrhea in the common cold. Am Rev Respir Dis 1981;123:418-20
   PubMedGoogle Scholar
• Eccles R, Pedersen A, Regberg D, et al. Efficacy and safety of topical combinations of ipratopium and xylometazoline for the treatment of symptoms of runny nose and nasal congestion associated with acute upper respiratory tract infection. Am J Rhinol 2007;21:40-5
   PubMedGoogle Scholar
• Tzachev CT, Mandajieva M, Minkov EH, Popov TA. Comparison of the clinical efficacy of standard and mucoadhesive-based nasal decongestants. J Clin Pharmacol 2002;53:107-9
   Web of Science ®Google Scholar
• Borum P. Nasal disorders and anticholinergic therapy. Postgrad Med J 1987;63:61-8
   PubMedGoogle Scholar
• Druce HM, Spector SL, Fireman P, et al. Double-blind study of intranasal ipratropium bromide in non-allergic perennial rhinitis. Ann Allergy 1992;69:53-60
   PubMedGoogle Scholar
• Bonadonna P, Senn G, Zanon P, et al. Cold-induced rhinitis in skiers – clinical aspects and treatment with ipratropium bromide nasal spray: a randomized controlled trial. Am J Rhinol 2001;15:297-301
   PubMedGoogle Scholar
• Milford CA, Mugliston TA, Lund VJ, Mackay IS. Long-term safety and efficacy study of intranasal ipratropium bromide. J Laryngol Otol 1990;104:123-5
   PubMedGoogle Scholar
• Castellano F, Mautone G. Decongestant activity of a new formulation of xylometazoline nasal spray: a double-blind, randomized versus placebo and reference drugs controlled, dose-effect study. Drugs Exp Clin Res 2002;27:27-35
   Google Scholar
• Pickering PN, Beardsmore CS. Nasal flow limitation in children. Pediatr Pulmonol 1999;27:32-6
   PubMed Web of Science ®Google Scholar
• Jessen M, Malm L. Use of pharmacologic decongestion in the generation of rhinomanometric norms for the nasal airway. Am J Otolaryngol 1988;9:336-40
   PubMed Web of Science ®Google Scholar
• Petruson B. Treatment with xylometazoline (Otrivin) nosedrops over a six-week period. Rhinology 1981;19:167-72
   PubMedGoogle Scholar
• Hochban W, Althoff H, Ziegler A. Nasal decongestion with imidazoline derivatives: acoustic rhinometry measurements. Eur J Clin Pharmacol 1999;55:7-12
   PubMed Web of Science ®Google Scholar
• Caenen M, Hamels K, Deron P, Clement P. Comparison of decongestive capacity of xylometazoline and pseudoephedrine with rhinomanometry and MRI. Rhinology 2005;43:205-9
   PubMed Web of Science ®Google Scholar
• Groth S, Dirksen H, Mygind N. The absence of systemic side-effects from high doses of ipratropium in the nose. Eur J Respir Dis 1983;64:490-3
   Google Scholar
• Eccles R, Jawad MS, Jawad S, et al. Efficacy and safety of single and multiple doses of pseudoephedrine in the treatment of nasal congestion associated with common cold. Am J Rhinol 2005;19:25-31
   PubMedGoogle Scholar
• Waddell AN, Patel SK, Toma AG, Maw AR. Intranasal steroid sprays in the treatment of rhinitis: is one better than another? J Laryngol Otol 2003;117:843-5
   PubMed Web of Science ®Google Scholar
• Watkinson J. Epistaxis. Sixth edition. In: Mackay IS, Bull TR, editors, Scott-Brown's otolaryngology. Oxford: Butterwoth-Heinemann, 1997. p. 4-18-1-19
   Google Scholar
• Graf P. Long-term use of oxy-and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity. Rhinology 1996;34:9-13
   PubMedGoogle Scholar
• Graf P. Adverse effects of benzalkonium chloride on the nasal mucosa: allergic rhinitis and rhinitis medicamentosa. Clin Ther 1999;21:1749-50
   PubMedGoogle Scholar
• Graf P. Rhinitis medicamentosa: a review of causes and treatment. Treat Resp Med 2005;4:21-9
   PubMedGoogle Scholar
• Hermens WAJJ, Merkus FWHM. The influence of drugs on nasal ciliary movement. Pharm Res 1987;4:445-9
   PubMed Web of Science ®Google Scholar
• Strandell B, Norgren-Holst E, Tran N, et al. OTC use of a topical nasal spray solution containing xylometazoline (0.5 mg/ml) plus ipratropium (0.6 mg/ml) in patients with common cold. Poster accepted for the 37th European Symposium on Clinical Pharmacy 2008, Pharmaceutical Care Models & Therapeutic Innovations, Dubrovnik, Croatia, 22-24 October 2008
   Google Scholar